United Kingdom
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
3,484.86%
|
March 31, 2024 | USD 10.94 | 1.86% |
|
United Kingdom |
|
2 |
356.25%
|
Aug. 31, 2023 | USD 0.16 | -0.68% |
|
United Kingdom |
|
3 |
59.51%
|
June 30, 2024 | USD 39.06 | 2.49% |
|
United Kingdom |
|
4 |
36.69%
|
June 30, 2024 | USD 1.47 | -0.73% |
|
United Kingdom |
|
5 |
29.08%
|
Dec. 30, 2023 | USD 72.03 | -1.91% |
|
United Kingdom |
|
6 |
28.75%
|
Dec. 31, 2023 | USD 0.21 | 6.16% |
|
United Kingdom |
|
7 |
19.44%
|
Dec. 31, 2023 | USD 45.94 | 0.03% |
|
United Kingdom |
|
8 |
16.25%
|
Dec. 31, 2023 | USD 15.79 | -2.73% |
|
United Kingdom |
|
9 |
15.47%
|
June 30, 2024 | USD 4.76 | -2.41% |
|
United Kingdom |
|
10 |
13.21%
|
March 31, 2024 | USD 32.51 | 0.69% |
|
United Kingdom |
|
11 |
13.00%
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
12 |
12.59%
|
Dec. 31, 2023 | USD 2.66 | 14.48% |
|
United Kingdom |
|
13 |
12.37%
|
March 31, 2024 | USD 2.90 | -3.96% |
|
United Kingdom |
|
14 |
11.25%
|
Dec. 31, 2023 | USD 59.37 | -0.51% |
|
United Kingdom |
|
15 |
9.53%
|
Dec. 31, 2023 | USD 0.78 | 0.09% |
|
United Kingdom |
|
16 |
9.41%
|
Sept. 30, 2024 | USD 5.40 | -1.25% |
|
United Kingdom |
|
17 |
9.28%
|
Dec. 31, 2023 | USD 4.48 | -0.21% |
|
United Kingdom |
|
18 |
6.61%
|
Dec. 31, 2023 | USD 24.44 | -0.21% |
|
United Kingdom |
|
19 |
6.43%
|
April 30, 2024 | USD 0.64 | 0.47% |
|
United Kingdom |
|
20 |
6.08%
|
Dec. 31, 2023 | USD 2.80 | 1.24% |
|
United Kingdom |
|
21 |
4.74%
|
Dec. 31, 2023 | USD 11.94 | -0.50% |
|
United Kingdom |
|
22 |
4.47%
|
Dec. 31, 2023 | USD 0.31 | 0.09% |
|
United Kingdom |
|
23 |
4.18%
|
Sept. 30, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
24 |
2.36%
|
Dec. 31, 2023 | USD 6.20 | -2.97% |
|
United Kingdom |
|
25 |
1.79%
|
Dec. 31, 2023 | USD 0.46 | 0.09% |
|
United Kingdom |
|
26 |
1.61%
|
Dec. 31, 2023 | USD 2.92 | -0.33% |
|
United Kingdom |
|
27 |
1.52%
|
Dec. 31, 2023 | USD 47.63 | 0.66% |
|
United Kingdom |
|
28 |
1.17%
|
March 31, 2024 | USD 0.78 | -0.69% |
|
United Kingdom |
|
29 |
1.09%
|
Sept. 30, 2024 | USD 18.48 | 0.49% |
|
United Kingdom |
|
30 |
0.96%
|
June 30, 2024 | USD 9.99 | -0.88% |
|
United Kingdom |
|
31 |
-5.81%
|
Dec. 31, 2023 | USD 0.70 | -2.31% |
|
United Kingdom |
|
32 |
-15.91%
|
July 31, 2024 | USD 0.16 | -0.69% |
|
United Kingdom |
|
33 |
-16.04%
|
Jan. 31, 2024 | USD 0.16 | 0.87% |
|
United Kingdom |
|
34 |
-18.00%
|
Dec. 31, 2023 | USD 0.32 | 0.09% |
|
United Kingdom |
|
35 |
-18.34%
|
Dec. 31, 2023 | USD 0.75 | -0.07% |
|
United Kingdom |
|
36 |
-20.72%
|
June 30, 2024 | USD 0.10 | 0.09% |
|
United Kingdom |
|
37 |
-22.17%
|
Dec. 31, 2023 | USD 28.56 | -4.90% |
|
United Kingdom |
|
38 |
-25.96%
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
39 |
-34.66%
|
Dec. 31, 2023 | USD 5.03 | -1.57% |
|
United Kingdom |
|
40 |
-34.70%
|
Sept. 30, 2024 | USD 0.14 | 0.09% |
|
United Kingdom |
|
41 |
-48.59%
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
42 |
-65.72%
|
March 31, 2024 | USD 0.15 | 0.09% |
|
United Kingdom |
|
43 |
-72.86%
|
June 30, 2024 | USD 0.09 | 2.54% |
|
United Kingdom |
|
44 |
-107.31%
|
Dec. 31, 2023 | USD 0.62 | -2.80% |
|
United Kingdom |
|
45 |
-170.51%
|
Dec. 31, 2023 | USD 5.61 | -4.92% |
|
United Kingdom |
|
46 |
-175.89%
|
Dec. 31, 2023 | USD 4.79 | -4.31% |
|
United Kingdom |
|
47 |
-187.05%
|
Dec. 31, 2023 | USD 0.71 | 0.09% |
|
United Kingdom |
|
48 |
-195.95%
|
March 31, 2024 | USD 0.11 | -6.40% |
|
United Kingdom |
|
49 |
-210.03%
|
Dec. 31, 2023 | USD 0.37 | -1.16% |
|
United Kingdom |
|
50 |
-237.95%
|
June 30, 2024 | USD 0.19 | -3.04% |
|
United Kingdom |
The Pharmaceuticals company in United Kingdom with the highest Net Income Margin is Roivant Sciences Ltd. (NasdaqGS: ROIV) at 3,484.86%.
The Pharmaceuticals company in United Kingdom with the lowest Net Income Margin is Autolus Therapeutics plc (NasdaqGS: AUTL) at -12,272.26%.
The top 10 Pharmaceuticals companies in United Kingdom by Net Income Margin are Roivant Sciences Ltd., Oncimmune Holdings plc, Bioventix PLC, Arcontech Group plc, NIOX Group Plc, hVIVO plc, RELX PLC, GSK plc, Tristel PLC and Halma plc.
The bottom 10 Pharmaceuticals companies in United Kingdom by Net Income Margin are Autolus Therapeutics plc, Celadon Pharmaceuticals Plc, Barinthus Biotherapeutics plc, Virax Biolabs Group Limited, Centessa Pharmaceuticals plc, Tekcapital plc, Oxford BioDynamics Plc, Biodexa Pharmaceuticals Plc, 4basebio PLC and Akanda Corp..